NCT03819296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +61 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Pathologic Stage III Cutaneous Melanoma AJCC v8
Explore clinical trials studying Pathologic Stage III Cutaneous Melanoma AJCC v8. Study availability and eligibility vary by location and protocol.
11 public trials
2 recruiting studies
Pathologic Stage III Cutaneous Melanoma AJCC v8 trial results
Recruiting
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +71 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03554083
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, +3 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Completed
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +82 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
Active, Not Recruiting
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
NCT07259304
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, +158 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
NCT02650986
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +78 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
NCT03816332
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more
- Locations
-
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT03677739
- Conditions
- Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, +19 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
NCT04940299
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
NCT04990726
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma Stage IV, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Related conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8 (11)
- Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 (10)
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 (10)
- Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 (10)
- Neoplasms (9)
- Neoplasms by Site (9)
- Pathologic Stage IIID Cutaneous Melanoma AJCC v8 (8)
- Clinical Stage IV Cutaneous Melanoma AJCC v8 (7)